O-1656
http://dbpedia.org/resource/O-1656 an entity of type: Thing
O-1656 is a cannabinoid agonist which was invented by Billy R Martin and Raj K Razdan at Organix Inc in 2002. It is moderately selective for the CB2 receptor with a CB1 receptor affinity of 18 nM and a CB2 receptor affinity of 2 nM. Since it has a cycloheptyl ring attached to the phenol core, it falls outside the definition of a "cyclohexylphenol derivative", but may still be controlled by generic legislation in some jurisdictions.
rdf:langString
rdf:langString
O-1656
xsd:integer
71089423
xsd:integer
1095230991
rdf:langString
none
xsd:integer
22
xsd:integer
468083
xsd:integer
36
xsd:integer
2
xsd:integer
2
xsd:integer
58803980
rdf:langString
CCCCCCCC1=CCO
xsd:integer
1
rdf:langString
AECZEBWFCJESSN-UHFFFAOYSA-N
xsd:integer
280
rdf:langString
O-1656 is a cannabinoid agonist which was invented by Billy R Martin and Raj K Razdan at Organix Inc in 2002. It is moderately selective for the CB2 receptor with a CB1 receptor affinity of 18 nM and a CB2 receptor affinity of 2 nM. Since it has a cycloheptyl ring attached to the phenol core, it falls outside the definition of a "cyclohexylphenol derivative", but may still be controlled by generic legislation in some jurisdictions.
xsd:nonNegativeInteger
2569
xsd:string
468083-75-2
xsd:string
58803980